Milwaukee Health Department answers questions from Common Council members about J&J vaccine
-
2:26
Firefighters hoist Santa, superheroes to wave to patients inside...
-
1:49
’I’m so thankful for it’: Salvation Army provides Wisconin’s...
-
3:26
Post holiday rain and mild weather will dominate the forecast
-
2:22
Three Milwaukee firefighters are siblings spending Christmas...
-
3:03
’Miracle on 64th Street’ neighborhood holiday display collecting...
-
2:01
2 killed in shooting near 38th and Nash; 1 arrested in connection...
-
1:29
Free Christmas Eve meals provided to those who need them by Capuchin...
-
1:00
Shoppers hit the stores for last-minute Christmas Eve gifts
-
0:51
American Airlines passengers in Milwaukee see some delays, cancelations...
-
1:24
Spend Christmas Eve at SnowGlobe, Franklin Field’s 3rd annual...
-
3:51
Country Star Dustin Lynch Previews New Year’s Eve Live: Nashville’s...
-
2:42
A boost in temperatures despite the lack of sunshine
MILWAUKEE (CBS 58) —Everyone 16 and older can now get the COVID-19 vaccine across the country. That’s been the case in Wisconsin for a few weeks.
Milwaukee health officials are watching vaccination rates. At the same time, Common Council members have questions after the pausing of the Johnson & Johnson vaccine.
Last week, the CDC & FDA recommended a pause on the J&J vaccine over six reported cases of a blood clot. The cases were among more than 6.8 million doses of the Johnson & Johnson vaccine that had been given out around the country.
Milwaukee Health Commissioner Kirsten Johnson says about 1,540 people received the Johnson & Johnson vaccine from the Milwaukee Health Department.
She was asked if those who received the vaccine have been contacted.
“It’s challenging some, where they're shelters, some of the organizations have contacted everyone and made it public as possible,” said Johnson.
Dr. Ben Weston, with the Milwaukee County Office of Emergency Management, says they also reached out to people who had received it.
“Just notified them that there were these findings, the risk is very low, I think they still made a very good decision in getting the vaccine. If Johnson & Johnson is back and available in a week, I still think it's an outstanding vaccine.”